CA2338543C - Method of direct identification of compound efficacy at a g protein-coupled orphan receptor - Google Patents

Method of direct identification of compound efficacy at a g protein-coupled orphan receptor Download PDF

Info

Publication number
CA2338543C
CA2338543C CA002338543A CA2338543A CA2338543C CA 2338543 C CA2338543 C CA 2338543C CA 002338543 A CA002338543 A CA 002338543A CA 2338543 A CA2338543 A CA 2338543A CA 2338543 C CA2338543 C CA 2338543C
Authority
CA
Canada
Prior art keywords
receptor
leu
protein
ser
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002338543A
Other languages
English (en)
French (fr)
Other versions
CA2338543A1 (en
Inventor
Dominic P. Behan
Derek T. Chalmers
Chen W. Liaw
I-Lin Lin
Kevin P. Lowitz
Ruoping Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arena Pharmaceuticals Inc
Original Assignee
Arena Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharmaceuticals Inc filed Critical Arena Pharmaceuticals Inc
Publication of CA2338543A1 publication Critical patent/CA2338543A1/en
Application granted granted Critical
Publication of CA2338543C publication Critical patent/CA2338543C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002338543A 1998-07-31 1999-07-30 Method of direct identification of compound efficacy at a g protein-coupled orphan receptor Expired - Fee Related CA2338543C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US9487998P 1998-07-31 1998-07-31
US60/094,879 1998-07-31
US10630098P 1998-10-30 1998-10-30
US60/106,300 1998-10-30
US11090698P 1998-12-04 1998-12-04
US60/110,906 1998-12-04
US12185199P 1999-02-26 1999-02-26
US60/121,851 1999-02-26
PCT/US1999/017425 WO2000006597A2 (en) 1998-07-31 1999-07-30 Endogenous constitutively activated g protein-coupled orphan receptors

Publications (2)

Publication Number Publication Date
CA2338543A1 CA2338543A1 (en) 2000-02-10
CA2338543C true CA2338543C (en) 2009-12-29

Family

ID=27492754

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002338543A Expired - Fee Related CA2338543C (en) 1998-07-31 1999-07-30 Method of direct identification of compound efficacy at a g protein-coupled orphan receptor

Country Status (13)

Country Link
EP (1) EP1095275B1 (enExample)
JP (1) JP2002521681A (enExample)
CN (1) CN1231762C (enExample)
AT (1) ATE432472T1 (enExample)
AU (1) AU751080B2 (enExample)
CA (1) CA2338543C (enExample)
DE (1) DE69940923D1 (enExample)
DK (1) DK1095275T3 (enExample)
IL (1) IL140858A0 (enExample)
MX (1) MXPA01001176A (enExample)
NO (1) NO20010509L (enExample)
NZ (1) NZ509429A (enExample)
WO (1) WO2000006597A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
MXPA02009902A (es) 2000-04-07 2003-06-17 Arena Pharm Inc Receptores acoplados a proteina g, conocidos, activados constitutivamente, no endogenos.
AU2003218234A1 (en) * 2002-03-15 2003-09-29 Arena Pharmaceuticals, Inc. Methods of expressing non-endogenous g protein coupled receptors in cells
WO2003081256A2 (en) * 2002-03-22 2003-10-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21)
WO2004015422A2 (en) * 2002-08-05 2004-02-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1)
CA2511144A1 (en) * 2002-12-20 2004-07-08 7Tm Pharma A/S Ghrelin receptor inverse agonist for regulation of feeding behaviours
WO2005095990A1 (en) * 2004-03-25 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 52 (gpr52)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220715C (en) * 1995-06-07 2004-11-02 Praecis Pharmaceuticals Incorporated Functional bioassay for g-protein coupled receptor agonists and antagonists
WO1997011159A1 (en) * 1995-09-20 1997-03-27 Molecular Geriatrics Corporation Yeast receptor and g-protein fusion protein
NZ336479A (en) * 1997-04-14 2001-10-26 Arena Pharm Inc A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease

Also Published As

Publication number Publication date
DK1095275T3 (da) 2009-09-28
JP2002521681A (ja) 2002-07-16
CN1323396A (zh) 2001-11-21
IL140858A0 (en) 2002-02-10
MXPA01001176A (es) 2005-07-25
NZ509429A (en) 2002-06-28
AU751080B2 (en) 2002-08-08
WO2000006597A9 (en) 2000-07-13
DE69940923D1 (de) 2009-07-09
NO20010509L (no) 2001-03-19
WO2000006597A2 (en) 2000-02-10
ATE432472T1 (de) 2009-06-15
CA2338543A1 (en) 2000-02-10
EP1095275A2 (en) 2001-05-02
AU5545999A (en) 2000-02-21
WO2000006597A3 (en) 2000-05-18
CN1231762C (zh) 2005-12-14
EP1095275B1 (en) 2009-05-27
NO20010509D0 (no) 2001-01-30

Similar Documents

Publication Publication Date Title
US7097969B2 (en) Non-endogenous, constitutively activated known G protein-coupled receptors
JP4672866B2 (ja) 非内因性の構成的に活性化されたヒトｇタンパク質共役受容体
AU1769601A (en) Endogenous and non-endogenous versions of human G protein-coupled receptors
KR20010080882A (ko) 구성적으로 활성화된 비내생성 인간 ｇ 단백질 결합형수용체
EP1412372A2 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
US20030216390A1 (en) Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
CA2338543C (en) Method of direct identification of compound efficacy at a g protein-coupled orphan receptor
US20130165633A1 (en) Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
US20060240523A1 (en) Endogenous and non-endogenous versions of human G protein-coupled receptors
US20130309766A1 (en) Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
US7119190B2 (en) Endogenous and non-endogenous versions of human G protein-coupled receptors
US8440391B2 (en) Constitutively activated human G protein coupled receptors
EP2264068A1 (en) Non-endogenous, constitutively activated human G protein-coupled receptors
US20070072248A1 (en) Constitutively activated human G protein coupled receptors
US20150153327A1 (en) Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
CA2732120A1 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
JP2011172577A (ja) 非内在性の構成的に活性化されるヒトｇタンパク質共役型受容体
EP1137776A2 (en) Non-endogenous, constitutively activated human g protein-coupled receptors
AU2002248497A1 (en) Endogenous and non-endogenous versions of human G protein-coupled receptors

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130730